DRUG NHANES III - 2020

GENERIC DRUG NAME
ETHINYL ESTRADIOL; FERROUS FUMARATE; NORETHINDRONE
BETA-ADRENERGIC BLOCKING AGENTS - UNSPECIFIED
CENTRAL NERVOUS SYSTEM AGENTS - UNSPECIFIED
NONSTEROIDAL ANTI-INFLAMMATORY AGENTS - UNSPECIFIED
ANXIOLYTICS, SEDATIVES, AND HYPNOTICS - UNSPECIFIED
MISCELLANEOUS UNCATEGORIZED AGENTS - UNSPECIFIED
RESPIRATORY INHALANT PRODUCTS - UNSPECIFIED
THIAZIDE AND THIAZIDE-LIKE DIURETICS - UNSPECIFIED
OPHTHALMIC GLAUCOMA AGENTS - UNSPECIFIED
OPHTHALMIC ANTI-INFLAMMATORY AGENTS - UNSPECIFIED
MISCELLANEOUS OPHTHALMIC AGENTS - UNSPECIFIED
HMG-COA REDUCTASE INHIBITORS - UNSPECIFIED
MONOAMINE OXIDASE INHIBITORS - UNSPECIFIED
OPHTHALMIC ANTIHISTAMINES AND DECONGESTANTS - UNSPECIFIED
POLYETHYLENE GLYCOL 3350 WITH ELECTROLYTES
EPHEDRINE; PHENOBARBITAL; POTASSIUM IODIDE; THEOPHYLLINE
ACETAMINOPHEN; CAFFEINE; CHLORPHENIRAMINE; HYDROCODONE; PHENYLEPHRINE
HYDROCODONE; PHENIRAMINE; PHENYLEPHRINE; PHENYLPROPANOLAMINE; PYRILAMINE
CHLORPHENIRAMINE; CODEINE; PHENYLEPHRINE; POTASSIUM IODIDE
BACITRACIN; NEOMYCIN; POLYMYXIN B TOPICAL
GRAMICIDIN; NEOMYCIN; POLYMYXIN B OPHTHALMIC
NEOMYCIN; POLYMYXIN B; PREDNISOLONE OPHTHALMIC
DEXAMETHASONE; NEOMYCIN; POLYMYXIN B OPHTHALMIC
HYDROCORTISONE; NEOMYCIN; POLYMYXIN B OTIC
HYOSCYAMINE; METHENAM; M-BLUE; PHENYL SALICYLATE
HYDROCORTISONE; NEOMYCIN; POLYMYXIN B OPHTHALMIC
COLISTIN; HYDROCORTISONE; NEOMYCIN; THONZONIUM OTIC
BACITRACIN; HYDROCORTISONE; NEOMYCIN; POLYMYXIN B TOPICAL
INSULIN LISPRO; INSULIN LISPRO PROTAMINE
INSULIN ASPART; INSULIN ASPART PROTAMINE
CHLOROPHYLLIN COPPER COMPLEX; PAPAIN; UREA TOPICAL
EPOETIN BETA; METHOXY POLYETHYLENE GLYCOL
HYDROCORTISONE; LIDOCAINE TOPICAL W PSYLLIUM
HYOSCYAMINE; METHENAM; M-BLUE; SODIUM BIPHOSPHATE
HYOSCYAMINE; METHENA; MBLUE; PHENYLSAL; SODIUM BIPHOSPHATE
CARBETAPENTANE CITRATE; GUAIFENESIN; PHENYLEPHRINE; PHENYLPROPANOLAMINE
CITRIC ACID; SODIUM CITRATE; SODIUM BICARBONATE; TARTARIC ACID

DRUG CATEGORY NAME - CAT 1, LEV 2
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS
ANGIOTENSIN RECEPTOR BLOCKERS AND NEPRILYSIN INHIBITORS

DRUG CATEGORY NAME - CAT 1, LEV 3
MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND HYPNOTICS
POTASSIUM SPARING DIURETICS WITH THIAZIDES
ANTIADRENERGIC AGENTS (PERIPHERAL) WITH THIAZIDES
ANTIADRENERGIC AGENTS (CENTRAL) WITH THIAZIDES
ACE INHIBITORS WITH CALCIUM CHANNEL BLOCKING AGENTS
ANGIOTENSIN II INHIBITORS WITH THIAZIDES
ANGIOTENSIN II INHIBITORS WITH CALCIUM CHANNEL BLOCKERS
PERIPHERAL OPIOID RECEPTOR MIXED AGONISTS/ANTAGONISTS

DRUG CATEGORY NAME - CAT 3, LEV 3
MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND HYPNOTICS

INGREDIENT CATEGORY NAME - CAT 1, LEV 2
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS
MISCELLANEOUS CENTRAL NERVOUS SYSTEM AGENTS

INGREDIENT CATEGORY NAME - CAT 1, LEV 3
MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND HYPNOTICS
PERIPHERAL OPIOID RECEPTOR MIXED AGONISTS/ANTAGONISTS

INGREDIENT CATEGORY NAME - CAT 2, LEV 3
MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND HYPNOTICS

INGREDIENT CATEGORY NAME - CAT 3, LEV 3
MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND HYPNOTICS

INGREDIENT CATEGORY NAME - CAT 4, LEV 3
MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND HYPNOTICS

INGREDIENT CATEGORY NAME - CAT 5, LEV 3
MISCELLANEOUS ANXIOLYTICS, SEDATIVES AND HYPNOTICS